John Krystal, M.D.
Head of Scientific Advisory Board and Co-inventor of Yale IP. Dr. Krystal is the Chair of the Department of Psychiatry, Robert L. McNeil, Jr., Professor of Translational Research, and Professor of Neurobiology at the Yale University School of Medicine. His research has focused on disturbances in amino acid (glutamate, GABA) signaling in psychiatric disorders. He is Chief of Psychiatry at Yale-New Haven Hospital, Director of the NIAAA Center for the Translational Neuroscience of Alcoholism, Director of the Clinical Neuroscience Division of the VA National Center for PTSD and Co-Director of the Neuroimaging Core of the Consortium to Alleviate PTSD. He is a graduate of the University of Chicago, Yale University School of Medicine, and the Yale Psychiatry Residency Training Program. He has published more than 400 papers and reviews on the neurobiology and treatment of schizophrenia, alcoholism, post-traumatic stress disorder, and depression. His research program unites psychopharmacology, neuroimaging, and molecular genetics. Dr. Krystal has received a numerous national and international awards for his research.
Maurizio Fava, M.D.
Dr. Fava obtained his medical degree from the University of Padova School of Medicine and completed a residency training in endocrinology at the same university. After completing a residency training in psychiatry at the Massachusetts General Hospital, he has been Director of the Depression Clinical and Research Program since 1990 at the same hospital. Under Dr. Fava’s direction, the Depression Clinical and Research Program has become one of the most highly regarded depression programs in the country, conducting research projects in a variety of areas, including pharmacotherapy of resistant depression, neuroimaging, genetics, neurophysiology, neuroendocrinology, novel pharmacotherapies, alternative medicine, and psychotherapy.
Dr. Fava has authored or co-authored more than 400 original articles published in medical journals with international circulation. He has also edited six books, and published more than 50 chapters and 500 abstracts. Dr. Fava is also a well-known national and international speaker, having given more than 200 presentations at national and international meetings during his career in psychiatry. He is currently Executive Vice Chair for the Department of Psychiatry, Director of the Depression Clinical and Research Program, Executive Director of the Clinical Trials Network and Institute at Massachusetts General Hospital, and Slater Family Professor of Psychiatry at Harvard Medical School.
Gerard Sanacora, M.D.
Dr. Sanacora is Professor and Director of the Yale Depression Research Clinic. Dr. Sanacora’s work is concentrated largely on elucidating the pathophysiological mechanisms associated with mood and other neuropsychiatric disorders. He completed an NIH sponsored Medical Scientist Training Program at the State University New York at Stony Brook, earning his Ph.D. in Physiology and Biophysics in 1992 and his M.D. degree in 1994. He completed his residency and an NIH funded Neuroimaging Scientist Training Program Fellowship at Yale. Dr. Sanacora’s laboratory has provided several seminal studies highlighting the contributions of the glutamatergic neurotransmitter system to the pathophysiology and treatment of mood and anxiety disorders. Reflecting his contributions to the field, he received the Anna-Monkia Stiftung international award for the investigation of the biological substrate and functional disturbances of depression in 2009 and the Joel Elkes Research Award for Outstanding contributions to Psychopharmacology from the ACNP in 2011. Dr. Sanacora was elected a Fellow of the American College of Neuropsychopharmacology in 2012.